Journal of Anaesthesiology Clinical Pharmacology (Jan 2021)

Acute perioperative hyperlactatemia in oncoplastic reconstructive surgeries: What is the significance?

  • Preety M Roy,
  • Kamal Bharti,
  • Sudha Sinha,
  • Sangeeta Khanna,
  • Yatin Mehta

DOI
https://doi.org/10.4103/joacp.JOACP_297_19
Journal volume & issue
Vol. 37, no. 3
pp. 416 – 418

Abstract

Read online

Background and Aims: We aim to study the significance of intraoperative hyperlactatemia in reconstructive oncoplastic surgery. Material and Methods: A retrospective observational study was conducted on a cohort of patients who underwent reconstructive oncoplastic surgery with free flap for oral cancer over a 6-month period. The study population was divided into two groups based on peak lactate levels. Group N with peak lactate level less than 2 mmol/L and Group H peak lactate level more than 2 mmol/L. The various parameter studied were patient's comorbidities; intraoperative events (vasopressor requirement, blood transfusion, and duration of surgery); postoperative parameters including the need for re- exploration and duration of stay in hospital and intensive care unit. Results: The study demonstrates that intraoperative rise of lactate was not influenced by comorbidities. None of the intraoperative parameters studied influenced the lactate levels. Baseline lactate level was found to correlate with peak lactate level intraoperatively. But it was observed that there was normalization of lactate level within 24 hours postoperatively in both the groups. There was no difference in outcome parameters in the two groups. Conclusion: Intraoperative hyperlactatemia is not a significant prognostic factor for outcome in oncoplastic reconstructive surgery.

Keywords